…oss results in undoubted improvements. These conditions include type 2 diabetes mellitus, cardiovascular disease and metabolic dysfunction-associated st…
Metabolic dysfunction-associated steatotic liver disease
This disease is selected. Its supporting articles are shown below.
Articles mentioning Metabolic dysfunction-associated steatotic liver disease
40 articles · page 3 of 4…so be involved. Weight loss with lifestyle interventions, early CRC screening, bariatric surgery and use of GLP-1 receptor agonists…
…act synergistically to accelerate steatohepatitis, fibrosis and hepatocellular carcinoma. However, the precise mechanisms underlying liver injury in Met…
…d comorbidities were present at lower rates in individuals with MASLD without MALO and population controls (p<0.001).Conclusions Pati…
…patitis (MASH), which is linked to cirrhosis, liver failure and hepatocellular carcinoma. The recent approval of resmetirom and semaglutide1 2 for activ…
…commend HCC surveillance in patients with cirrhosis when annual HCC incidence exceeds 1% without specifying the role of non-invasiv…
…bule. It showed that inflammation burden was higher in AIH than MASLD/MASH, despite equivalent portal grades, providing objective sup…
…-induced liver injury and gastrointestinal malignancies such as hepatocellular carcinoma, colorectal and pancreatic cancers. CD47 contributes to disease…
…Objective Metabolic dysfunction-associated steatotic liver disease (MASLD) presents considerable variability in disease progressio…
…attributed to higher rates of alcohol-related liver disease and metabolic dysfunction-associated steatotic liver disease. Rifaximin, indicated for the secondary prevention of recurrent…
…hose who were food insecure had significantly increased odds of MASLD with fibrosis compared to those who were food secure, adjusted …
…ent, a Fibroscan, and completion liver screen. Interrogation of metabolic syndrome risk factors and alcohol screening takes place, with appropriat…